S
Shinichiro Ochi
Researcher at Ehime University
Publications - 75
Citations - 774
Shinichiro Ochi is an academic researcher from Ehime University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 49 publications receiving 463 citations. Previous affiliations of Shinichiro Ochi include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease
Yuki Ozaki,Yuta Yoshino,Kiyohiro Yamazaki,Tomoko Sao,Yoko Mori,Shinichiro Ochi,Taku Yoshida,Takaaki Mori,Jun-ichi Iga,Shu-ichi Ueno +9 more
TL;DR: Lower DNA methylation at TREM1 intron 1 caused higher TREM2 mRNA expression in the leukocytes of AD subjects versus controls and may be a biomarker for AD.
Journal ArticleDOI
DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies.
Yu Funahashi,Yuta Yoshino,Kiyohiro Yamazaki,Yoko Mori,Takaaki Mori,Yuki Ozaki,Tomoko Sao,Shinichiro Ochi,Jun-ichi Iga,Shu-ichi Ueno +9 more
TL;DR: Epigenetic changes at the synuclein alpha ( SNCA) gene may be involved in DLB pathogenesis, and accumulation of α‐synuclein aggregates causes synaptic dysfunction inDLB.
Journal ArticleDOI
Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
Kotaro Hatta,Koji Sato,Hiroshi Hamakawa,Hiroshi Takebayashi,Naoto Kimura,Shinichiro Ochi,Yasuhiko Sudo,Nozomu Asukai,Hiroyuki Nakamura,Chie Usui,Toshitaka Kawabata,Toyoaki Hirata,Yutaka Sawa +12 more
TL;DR: Olanzapine and risperidone are superior to quetiapines and aripiprazole for the acute treatment of psychosis in hospitalized patients.
Journal ArticleDOI
MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease.
Tomoko Sao,Yuta Yoshino,Kiyohiro Yamazaki,Yuki Ozaki,Yoko Mori,Shinichiro Ochi,Taku Yoshida,Takaaki Mori,Jun-ichi Iga,Shu-ichi Ueno +9 more
TL;DR: Myocyte‐enhancer factor 2C (MEF2C) is one of several genes influence AD pathogenesis by affecting inflammatory pathways and is a candidate gene for AD.
Journal ArticleDOI
INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
Yuta Yoshino,Kiyohiro Yamazaki,Yuki Ozaki,Tomoko Sao,Taku Yoshida,Takaaki Mori,Yoko Mori,Shinichiro Ochi,Jun-ichi Iga,Shu-ichi Ueno +9 more
TL;DR: It is suggested that INPP5D mRNA expression was elevated in the early stage and decreased with cognitive decline in AD and may be a useful biomarker for the early stages of AD.